Delivery Order SPE2DB24D2010-SPE2DB25FABDF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,239.43 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100-count units) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,573.86 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count). This firm fixed-price contract, with an ultimate completion date of August 14, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,454.40 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency Troop Support Medical awarded a $239,630 delivery order contract to Amerisourcebergen Drug Corporation for the provision of 100 tablets of Estrogen-Methyltestos H.S. The contract has a firm fixed price and will be performed in Conshohocken, Pennsylvania over a one day period from September 13, 2023 to September 14, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order from DLA Troop Support Medical is consistent...
- The Defense Logistics Agency Troop Support Medical awarded a $416,990 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the purchase of 100 tablets of Estrogen-Methyltestos F.S. tablets. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the Department of Defense through the procurement and...
- The Defense Logistics Agency Troop Support Medical awarded a $554,640 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of 100 tablets of Estrogen-Methyltestos H.S. The contract has a period of performance from August 31, 2023 through September 1, 2023 and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the...
- The Defense Logistics Agency Troop Support Medical awarded a $224,040 delivery order contract to Amerisourcebergen Drug Corporation for the purchase of 100 units of Estrogen-Methyltestos F.S. tablets. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The firm fixed price contract runs from July 5, 2023 through July 6, 2023 to supply the Defense Logistics Agency with the specified pharmaceutical products in...
- The Defense Logistics Agency awarded a $448 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 100 units of Estrogen-Methyltestos H.S. tablets. The contract has a period of performance from August 18-21, 2023, with all work to be conducted by the prime contractor in Conshohocken, Pennsylvania. As the DLA supports medical readiness for the Department of Defense, this delivery order is likely associated with stocking pharmaceuticals for military treatment...
- The Defense Logistics Agency awarded a $214,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 4,562 units of Estrogen-Methyltestos F.S. tablets. The order is to be fulfilled by Amerisourcebergen's Corporate Office Division facility located in Conshohocken, Pennsylvania, with all items to be delivered between September 15-18, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. military and other government agencies, this...
- This federal contract award, valued at $1,195.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of "ESTROGEN-METHYLTESTOS F.S. TAB 100S", a pharmaceutical product. The contract has an ultimate completion date of December 3, 2024 and is a Firm Fixed Price agreement. There is no set-aside designation on this award. Amerisourcebergen...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABDFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,071.28 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to serve as a critical vendor for federal medical procurement needs through this transaction. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA's Pharmaceutical Prime Vendor Global Program represents a strategic approach utilizing multiple contractors across separate regions to ensure robust and flexible pharmaceutical supply chain capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/10/25 |